FT News Briefing
Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
Wed, 26 Aug 2020
European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US. Covid-19 vaccine makers lobby EU for legal protectionhttps://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?Low rates help propel US homebuilder stocks to record highshttps://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22Ant Group reveals $2.6bn profit as it files for blockbuster IPOhttps://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster